ConductScience.org, home

Paper11697106

Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential.

Sekido T and 11 others. J Drug Target, 2001. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential. Papers, record 11697106. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11697106

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential.
PubMed
Journal
J Drug Target
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
1.39
iCite
Revised in PubMed
2022-03-09
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sekido TT
2Sakura NN
3Higashi YY
4Miya KK
5Nitta YY
6Nomura MM
7Sawanishi HH
8Morito KK
9Masamune YY
10Kasugai SS
11Yokogawa KK
12Miyamoto KK

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone and BonesMajor topic
OligopeptidesMajor topic
Acids
Animals
Chromatography, High Pressure Liquid
Drug Carriers
Drug Delivery Systems
Durapatite
Estradiol
Female
Fluorenes
Mice
Osteoporosis
Ovariectomy
Receptors, Estrogen

Source PubMed

Download CSV of topics

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
42410273Nanodrug delivery systems enhance traditional Chinese medicine treatment of osteoporosis.Discov Nano2026https://conductscience.org/library/papers/42410273PubMed
41725887Nanoparticles Targeting the Tumor Microenvironment for the Treatment of Osteosarcoma: Recent Progress and Perspectives.Int J Nanomedicine2026https://conductscience.org/library/papers/41725887PubMed
40954411Image-guided in vivo evaluation and comparison of bone-targeting peptides for therapeutic intervention.Drug Deliv Transl Res2026https://conductscience.org/library/papers/40954411PubMed
38661537Advances in Bone-Targeting Drug Delivery: Emerging Strategies Using Adeno-Associated Virus.Hum Gene Ther2024https://conductscience.org/library/papers/38661537PubMed
38449313Engineering small-molecule and protein drugs for targeting bone tumors.Mol Ther2024https://conductscience.org/library/papers/38449313PubMed
38371454Bone Targeting Nanoparticles for the Treatment of Osteoporosis.Int J Nanomedicine2024https://conductscience.org/library/papers/38371454PubMed
38056586Integrating osteoimmunology and nanoparticle-based drug delivery systems for enhanced fracture healing.Nanomedicine2024https://conductscience.org/library/papers/38056586PubMed
37198232Targeting strategies for bone diseases: signaling pathways and clinical studies.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37198232PubMed
36768328Targeting Agents in Biomaterial-Mediated Bone Regeneration.Int J Mol Sci2023https://conductscience.org/library/papers/36768328PubMed
36380167Bone-Targeted Dual Functional Lipid-coated Drug Delivery System for Osteosarcoma Therapy.Pharm Res2023https://conductscience.org/library/papers/36380167PubMed
35712701Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease.Front Pharmacol2022https://conductscience.org/library/papers/35712701PubMed
35517758A novel biocompatible, simvastatin-loaded, bone-targeting lipid nanocarrier for treating osteoporosis more effectively.RSC Adv2020https://conductscience.org/library/papers/35517758PubMed
35455393Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35455393PubMed
35119364Induction of osteogenesis by bone-targeted Notch activation.Elife2022https://conductscience.org/library/papers/35119364PubMed
32957602Poly(Aspartic Acid) Functionalized Poly(ϵ-Caprolactone) Microspheres with Enhanced Hydroxyapatite Affinity as Bone Targeting Antibiotic Carriers.Pharmaceutics2020https://conductscience.org/library/papers/32957602PubMed
32930474Fluorescent Self-Threaded Peptide Probes for Biological Imaging.Angew Chem Int Ed Engl2020https://conductscience.org/library/papers/32930474PubMed
32860563Bone-Targeting Systems to Systemically Deliver Therapeutics to Bone Fractures for Accelerated Healing.Curr Osteoporos Rep2020https://conductscience.org/library/papers/32860563PubMed
32845464Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders.Curr Osteoporos Rep2020https://conductscience.org/library/papers/32845464PubMed
32601412Selection and identification of a novel bone-targeting peptide for biomedical imaging of bone.Sci Rep2020https://conductscience.org/library/papers/32601412PubMed
31019230Effect of enzyme replacement therapy on the growth of patients with Morquio A.J Hum Genet2019https://conductscience.org/library/papers/31019230PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11697106

GET https://conductscience.org/api/papers/v1/11697106/cited_by?page=2